Privacy-Preserving Active Learning for precision oncology clinical workflows with inverse simulation verification
Privacy-Preserving Active Learning for precision oncology clinical workflows with inverse simulation verification When I first started exploring the intersection of federated learning and clinical decision support, I assumed the hard part would be the math. I was wrong. The hard part was trust — specifically, how do you prove that a model trained on data it never saw actually learned something…
Title: Privacy-Preserving Active Learning for Precision Oncology Clinical Workflows with Inverse Simulation Verification
When the author first started exploring the intersection of federated learning and clinical decision support, they were surprised by the challenging aspect. It was not the math, but the trust — specifically, how to prove that a model trained on data it never saw learned something clinically meaningful. This question led the author to a rabbit hole that eventually resulted in a working prototype combining privacy-preserving active learning with a verification mechanism.
The article discusses the architecture built, privacy guarantees implemented, the active learning loop for labeling across siloed hospital sites, and the inverse simulation verification layer that allows clinicians to falsify audit model behavior. Precision oncology, which matches treatments to a patient's tumor molecular profile, presents unique challenges for privacy-preserving machine learning (ML).
The data is highly sensitive, with genomic sequences that can re-identify individuals, treatment histories revealing personal information, and small datasets per institution.
The author noticed a significant mismatch between federated learning frameworks and oncology data. Most tutorials optimize for image classification with IID shards, but oncology data is heavily non-IID, class-imbalanced, and has label scarcity. Active learning was identified as the natural complement to federation. The core architecture consists of a central orchestrator, a global model registry, an acquisition planner, an inverse simulator, and a verifier.
Federated training with client-level differential privacy was employed, with a focus on clipping strategy and handling site heterogeneity. Per-example gradient clipping at a fixed norm proved ineffective for oncology. Instead, the author used per-feature-group adaptive clipping with a running quantile estimate. This approach accounts for the varying scales of feature data and ensures privacy accounting for the gradient norm distribution.
Written by urgent.news from Dev.to's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
